Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factors predisposing to cancer

H C Pitot

    Science (New York, N.Y.)
    |July 17, 1981
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.

    Cardiovascular and interventional radiology·2005
    Same author

    Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling.

    BMC bioinformatics·2005
    Same author

    Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2003
    Same author

    A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin.

    Annals of oncology : official journal of the European Society for Medical Oncology·2002
    Same author

    Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2002